During PAH pathogenesis, the platelet-derived growth factor (PDGF) has been identified as a major trigger of unregulated PASMCs’ proliferation and migration, leading to vascular remodeling via highly selective receptor tyrosine kinases [16]. Here, NTRK1 is linked to pulmonary arterial hypertension.